Found 7 articles
After the FDA released draft guidance on increasing diversity in clinical trials, companies have been left to figure out the details. Here’s what experts say is working.
Curavit Raises $5 Million in Series A Funding to Accelerate Growth in Digital Therapeutics Clinical Research
Curavit Clinical Research today announced it raised $5 million in Series A funding to accelerate its growing portfolio of research in the global digital therapeutics (DTx) market (projected to grow at a CAGR of 31.4% through 2026).
ixlayer Partners with Curavit to Enable Convenient Patient Medical Testing Services for Decentralized Clinical Trials
Curavit Clinical Research, a virtual contract research organization (VCRO), has entered into a long-term partnership with ixlayer to provide easy access to clinical-grade diagnostic lab testing for decentralized clinical trials (DCTs).
Swing Therapeutics Selects Curavit to Provide Virtual Trial Site Services for Novel Digital Therapeutic Study for Fibromyalgia
Curavit Clinical Research, a virtual contract research organization (VCRO), has been selected by digital therapeutics company, Swing Therapeutics, to be a virtual site for its pivotal trial of an investigational digital therapeutic (DTx) for fibromyalgia.
Beechtree Labs has chosen Curavit Clinical Research for a fully decentralized clinical trial to investigate a promising Covid-19 therapy.
Curavit Clinical Research and eMoyo USA, LLC Partner to Deliver High-Quality Home-Based Audiometric Data for Virtual Clinical Trials.
Curavit Clinical Research, a virtual research organization, and eMoyo USA, LLC, the USA representative of eMoyo, a global leader in healthcare technology, announced a partnership to pave the way for hearing research studies to continue during the COVID-19 pandemic.
Industry veterans Joel Morse and Dave Hanaman announce the formation of a company to lead into the future of clinical trials